These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 22760211

  • 1. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
    Sun H, Zheng X, Wang Q, Yan J, Li D, Zhou Y, Lin Y, Zhang L, Wang X.
    Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
    [Abstract] [Full Text] [Related]

  • 2. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN, Wang X, Zheng XL, Sun H, Shi XW, Zhong YJ, Huang B, Yang L, Li JK, Liao LC, Zhang L, Hu LN, Lin Y.
    Cancer Lett; 2010 Sep 01; 295(1):38-43. PubMed ID: 20207071
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.
    Wang X, Chen W, Lin Y.
    Biochem Biophys Res Commun; 2007 Apr 13; 355(3):807-12. PubMed ID: 17316570
    [Abstract] [Full Text] [Related]

  • 4. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
    Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, Zhu LX, Zhou Q, Zhao YF.
    Apoptosis; 2010 Jul 13; 15(7):850-63. PubMed ID: 20386985
    [Abstract] [Full Text] [Related]

  • 5. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR, Park CG, Jung JY.
    Int J Mol Med; 2014 Feb 13; 33(2):317-24. PubMed ID: 24285354
    [Abstract] [Full Text] [Related]

  • 6. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
    Sun ZJ, Chen G, Zhang W, Hu X, Liu Y, Zhou Q, Zhu LX, Zhao YF.
    Mol Pharmacol; 2011 Jan 13; 79(1):106-18. PubMed ID: 20959361
    [Abstract] [Full Text] [Related]

  • 7. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH, Jang AH, Yoo CG.
    Am J Respir Cell Mol Biol; 2015 Sep 13; 53(3):412-21. PubMed ID: 25633180
    [Abstract] [Full Text] [Related]

  • 8. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT, Chen H, Ni ZL, Liu HB, Tong HF, Fan L, Liu A, Qiu MX, Liu DL, Guo HC, Wang ZH, Lin SZ.
    Int J Oncol; 2011 Dec 13; 39(6):1381-90. PubMed ID: 21805032
    [Abstract] [Full Text] [Related]

  • 9. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M, Liu ZM, Li XC, Yao YT, Yin ZX.
    J Chemother; 2013 Jun 13; 25(3):162-9. PubMed ID: 23783141
    [Abstract] [Full Text] [Related]

  • 10. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW, Jiang XX, Chen QS, Shi WY, Wang L, Sun HD, Shen ZX, Chen Z, Chen SJ, Zhao WL.
    Exp Hematol; 2010 Mar 13; 38(3):191-201. PubMed ID: 20045442
    [Abstract] [Full Text] [Related]

  • 11. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
    Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R.
    Cancer Lett; 2009 Dec 28; 286(2):206-16. PubMed ID: 19553005
    [Abstract] [Full Text] [Related]

  • 12. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y, Yang G, Hong Y.
    Cancer Lett; 2015 Feb 28; 357(2):520-6. PubMed ID: 25499080
    [Abstract] [Full Text] [Related]

  • 13. 4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells.
    Kim SG, Lee SW, Park YW, Jeong JH, Choi JY.
    Oncol Rep; 2011 Dec 28; 26(6):1527-32. PubMed ID: 21874263
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z, Li M, Wang R, Xiao Q, Wang J, Li M, He D, Xiao X.
    Mol Cancer Res; 2014 Mar 28; 12(3):335-47. PubMed ID: 24362251
    [Abstract] [Full Text] [Related]

  • 15. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M, Wienrich BG, Kneitz S, Sennefelder H, Amschler K, Vöhringer V, Weber O, Stiewe T, Ziegelbauer K, Schön MP.
    J Natl Cancer Inst; 2008 Jun 18; 100(12):862-75. PubMed ID: 18544741
    [Abstract] [Full Text] [Related]

  • 16. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.
    Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823
    [Abstract] [Full Text] [Related]

  • 17. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.
    Oncogene; 2011 Jul 14; 30(28):3139-52. PubMed ID: 21317920
    [Abstract] [Full Text] [Related]

  • 18. Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.
    Bai L, Xu S, Chen W, Li Z, Wang X, Tang H, Lin Y.
    Apoptosis; 2011 Jan 14; 16(1):45-54. PubMed ID: 20862547
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G, Gekeler V, Leja A, Beckers T, Boehm M.
    Cancer Res; 2006 May 15; 66(10):5409-18. PubMed ID: 16707469
    [Abstract] [Full Text] [Related]

  • 20. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R, Yang F, Chang SH, Tang J, Qin J, Feng GK, Ding K, Zhu XF.
    Mol Pharmacol; 2012 Aug 15; 82(2):189-98. PubMed ID: 22553359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.